# Effect of HCL Insulin Delivery System on Glycemic Control in Patients With T1D

> **NCT05924932** · — · UNKNOWN · sponsor: **Masaryk Hospital Usti nad Labem** · enrollment: 120 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DEVICE:** Tandem t:slim X2 with hybrid closed loop system Control IQ, glucose sensor: Dexcom G6
- **DEVICE:** MiniMed 780G, with hybrid closed loop system SmartGuard, sensor Guardien 4

## Key facts

- **NCT ID:** NCT05924932
- **Lead sponsor:** Masaryk Hospital Usti nad Labem
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05924932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05924932, "Effect of HCL Insulin Delivery System on Glycemic Control in Patients With T1D". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT05924932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*